Acceptability of Implantable Continuous Glucose Monitoring Sensor

Journal of Diabetes Science and Technology

Volumn 12, Issue 3, 2018, Pages 634-638

  Barnard, Katharine D ^a,b   Kropff, Jort ^c   Choudhary, Pratik ^d   Neupane, Sankalpa ^e   Bain, Stephen C ^f   Kapitza, Christoph ^g   Forst, Thomas ^h   Link, Manuela ⁱ   Mdingi, Colleen ^j   DeVries, J Hans ^c  

^a BOURNEMOUTH UNIVERSITY   (United Kingdom)

^b BHR Limited   (United Kingdom)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^f SWANSEA UNIVERSITY   (United Kingdom)

^g Profil   (Germany)

^h Profil Mainz   (Germany)

ⁱ UNIVERSITY OF ULM   (Germany)

^j Senseonics   (United States)

more..

Author keywords

continuous glucose monitoring; implantable; psychosocial; type 1 diabetes

Indexed keywords

INSULIN;

ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE BURDEN; HUMAN; HYPOGLYCEMIA; LATENT AUTOIMMUNE DIABETES IN ADULTS; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY; PSYCHOLOGIC ASSESSMENT; QUALITY OF LIFE; QUESTIONNAIRE; SLEEP; ADOLESCENT; ADULT; ANALYSIS; BLOOD; DEVICES; FEMALE; GLUCOSE BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MULTICENTER STUDY; PATIENT ATTITUDE; PSYCHOLOGY;

ADOLESCENT; ADULT; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; SURVEYS AND QUESTIONNAIRES;

EID: 85042093821     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/1932296817735123     Document Type: Article

References (12)

1. Riveline JP., Is continuous glucose monitoring (CGM) for everyone? To whom should CGM be prescribed and how? Diabetes Metab. 2011;37:80-84.
2. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring (JDRF-CGM) trial. Diabetes Care. 2009;33(1):17-22.
3. Little SA, Leelarathna L, Walkinshaw E. Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multi-center 2x2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaSS). Diabetes Care. 2014;37(8):2114-2122.
4. Ritholz MD, Atakov-Castillo A, Beste M. Psychosocial factors associated with use of continuous glucose monitoring. Diabet Med. 2010;27(9):1060-1065.
5. Barnard KD, Wysocki T, Allen J. Closing the loop overnight at home setting: psychosocial impact for adolescents with type 1 diabetes and their parents. BMJ Open Diabetes Res Care. 2014;2(1):e000025.
6. Kropff J, Choudhary P, Neupane S. Accuracy and longevity of an implantable continuous glucose sensor in the PRECISE study: a 180-day prospective, multicenter, pivotal trial. Diabetes Care. 2017;40(1):63-68.
7. Fisher L, Glasgow RE, Mullan JT, Skaff MM, Polonsky WH., Development of a brief diabetes distress screening instrument. Ann Farm Med. 2008;6(3):246-252.
8. Polonsky WH, Fisher L, Hessler D, Edelman SV., Development of a new measure for assessing glucose monitoring device-related treatment satisfaction and quality of life. Diabetes Technol Ther. 2015;17(9):657-663.
9. Wong JC, Foster NC, Maahs DM. Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry. Diabetes Care. 2014;37(10):2702-2709.
10. Pickup JC, Freeman SC, Sutton AJ., Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data. BMJ. 2011;343:1-14.
11. Barnard KD, Kubiak T, Hermanns N, Heinemann L., Heinemann patient-reported outcomes and continuous glucose monitoring: can we do better with artificial pancreas devices? Diabetes Care. 2015;38(5):e70.
12. Hoffman A., Enhancing self-efficacy for optimized patient outcomes through the theory of symptom self-management. Cancer Nurs. 2013;36(1):e16-e26.